Selected research
Industry Research
Tiopronin Industry Research Report 2026
Market perspective
The global Tiopronin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tiopronin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tiopronin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tiopronin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tiopronin include Wuhan Yuanda Pharmaceutical Group, Shanghai Kaibao Pharmaceutical Co., Ltd., Jiangsu Desano Pharmaceutical Co. Ltd, Henan Xinyi Pharmaceutical Group, Hangzhou Minsheng Pharmaceutical Co. Ltd, Sinopharm Guorui Pharmaceutical Co. Ltd, Changzhou Yabang Pharmaceutical Co. Ltd, Clinigen Direct and AdvaCare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tiopronin market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tiopronin Market by Company
Wuhan Yuanda Pharmaceutical Group
Shanghai Kaibao Pharmaceutical Co., Ltd.
Jiangsu Desano Pharmaceutical Co. Ltd
Henan Xinyi Pharmaceutical Group
Hangzhou Minsheng Pharmaceutical Co. Ltd
Sinopharm Guorui Pharmaceutical Co. Ltd
Changzhou Yabang Pharmaceutical Co. Ltd
Clinigen Direct
AdvaCare
Tiopronin Segment by Type
Injection
Tablet
Capsule
Tiopronin Segment by Application
Early Senile Cataract
Eczema
Fatty liver Disease
Tiopronin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tiopronin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tiopronin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tiopronin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tiopronin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tiopronin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tiopronin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablet
- Capsule
Applications
- Early Senile Cataract
- Eczema
- Fatty liver Disease
Companies covered
- Wuhan Yuanda Pharmaceutical Group
- Shanghai Kaibao Pharmaceutical Co., Ltd.
- Jiangsu Desano Pharmaceutical Co. Ltd
- Henan Xinyi Pharmaceutical Group
- Hangzhou Minsheng Pharmaceutical Co. Ltd
- Sinopharm Guorui Pharmaceutical Co. Ltd
- Changzhou Yabang Pharmaceutical Co. Ltd
- Clinigen Direct
- AdvaCare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tiopronin Market Size (2021-2032)
- 2.2.2 Global Tiopronin Sales (2021-2032)
- 2.2.3 Global Tiopronin Market Average Price (2021-2032)
- 2.3 Tiopronin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Tablet
- 2.3.4 Capsule
- 2.4 Tiopronin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Early Senile Cataract
- 2.4.3 Eczema
- 2.4.4 Fatty liver Disease
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tiopronin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tiopronin Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Tiopronin Revenue of Manufacturers (2021-2026)
- 3.4 Global Tiopronin Average Price by Manufacturers (2021-2026)
- 3.5 Global Tiopronin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tiopronin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tiopronin, Product Type & Application
- 3.8 Global Manufacturers of Tiopronin, Established Date
- 3.9 Global Tiopronin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wuhan Yuanda Pharmaceutical Group
- 4.1.1 Wuhan Yuanda Pharmaceutical Group Company Information
- 4.1.2 Wuhan Yuanda Pharmaceutical Group Business Overview
- 4.1.3 Wuhan Yuanda Pharmaceutical Group Tiopronin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wuhan Yuanda Pharmaceutical Group Tiopronin Product Portfolio
- 4.1.5 Wuhan Yuanda Pharmaceutical Group Recent Developments
- 4.2 Shanghai Kaibao Pharmaceutical Co., Ltd.
- 4.2.1 Shanghai Kaibao Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Shanghai Kaibao Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Shanghai Kaibao Pharmaceutical Co., Ltd. Tiopronin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Kaibao Pharmaceutical Co., Ltd. Tiopronin Product Portfolio
- 4.2.5 Shanghai Kaibao Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Jiangsu Desano Pharmaceutical Co. Ltd
- 4.3.1 Jiangsu Desano Pharmaceutical Co. Ltd Company Information
- 4.3.2 Jiangsu Desano Pharmaceutical Co. Ltd Business Overview
- 4.3.3 Jiangsu Desano Pharmaceutical Co. Ltd Tiopronin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangsu Desano Pharmaceutical Co. Ltd Tiopronin Product Portfolio
- 4.3.5 Jiangsu Desano Pharmaceutical Co. Ltd Recent Developments
- 4.4 Henan Xinyi Pharmaceutical Group
- 4.4.1 Henan Xinyi Pharmaceutical Group Company Information
- 4.4.2 Henan Xinyi Pharmaceutical Group Business Overview
- 4.4.3 Henan Xinyi Pharmaceutical Group Tiopronin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Henan Xinyi Pharmaceutical Group Tiopronin Product Portfolio
- 4.4.5 Henan Xinyi Pharmaceutical Group Recent Developments
- 4.5 Hangzhou Minsheng Pharmaceutical Co. Ltd
- 4.5.1 Hangzhou Minsheng Pharmaceutical Co. Ltd Company Information
- 4.5.2 Hangzhou Minsheng Pharmaceutical Co. Ltd Business Overview
- 4.5.3 Hangzhou Minsheng Pharmaceutical Co. Ltd Tiopronin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hangzhou Minsheng Pharmaceutical Co. Ltd Tiopronin Product Portfolio
- 4.5.5 Hangzhou Minsheng Pharmaceutical Co. Ltd Recent Developments
- 4.6 Sinopharm Guorui Pharmaceutical Co. Ltd
- 4.6.1 Sinopharm Guorui Pharmaceutical Co. Ltd Company Information
- 4.6.2 Sinopharm Guorui Pharmaceutical Co. Ltd Business Overview
- 4.6.3 Sinopharm Guorui Pharmaceutical Co. Ltd Tiopronin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sinopharm Guorui Pharmaceutical Co. Ltd Tiopronin Product Portfolio
- 4.6.5 Sinopharm Guorui Pharmaceutical Co. Ltd Recent Developments
- 4.7 Changzhou Yabang Pharmaceutical Co. Ltd
- 4.7.1 Changzhou Yabang Pharmaceutical Co. Ltd Company Information
- 4.7.2 Changzhou Yabang Pharmaceutical Co. Ltd Business Overview
- 4.7.3 Changzhou Yabang Pharmaceutical Co. Ltd Tiopronin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Changzhou Yabang Pharmaceutical Co. Ltd Tiopronin Product Portfolio
- 4.7.5 Changzhou Yabang Pharmaceutical Co. Ltd Recent Developments
- 4.8 Clinigen Direct
- 4.8.1 Clinigen Direct Company Information
- 4.8.2 Clinigen Direct Business Overview
- 4.8.3 Clinigen Direct Tiopronin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Clinigen Direct Tiopronin Product Portfolio
- 4.8.5 Clinigen Direct Recent Developments
- 4.9 AdvaCare
- 4.9.1 AdvaCare Company Information
- 4.9.2 AdvaCare Business Overview
- 4.9.3 AdvaCare Tiopronin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AdvaCare Tiopronin Product Portfolio
- 4.9.5 AdvaCare Recent Developments
5 Global Tiopronin Market Scenario by Region
- 5.1 Global Tiopronin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tiopronin Sales by Region: 2021-2032
- 5.2.1 Global Tiopronin Sales by Region: 2021-2026
- 5.2.2 Global Tiopronin Sales by Region: 2027-2032
- 5.3 Global Tiopronin Revenue by Region: 2021-2032
- 5.3.1 Global Tiopronin Revenue by Region: 2021-2026
- 5.3.2 Global Tiopronin Revenue by Region: 2027-2032
- 5.4 North America Tiopronin Market Facts & Figures by Country
- 5.4.1 North America Tiopronin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tiopronin Sales by Country (2021-2032)
- 5.4.3 North America Tiopronin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Tiopronin Market Facts & Figures by Country
- 5.5.1 Europe Tiopronin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tiopronin Sales by Country (2021-2032)
- 5.5.3 Europe Tiopronin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Tiopronin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tiopronin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tiopronin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tiopronin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tiopronin Market Facts & Figures by Country
- 5.7.1 South America Tiopronin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tiopronin Sales by Country (2021-2032)
- 5.7.3 South America Tiopronin Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Tiopronin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tiopronin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tiopronin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tiopronin Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Tiopronin Sales by Type (2021-2032)
- 6.1.1 Global Tiopronin Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Tiopronin Sales Market Share by Type (2021-2032)
- 6.2 Global Tiopronin Revenue by Type (2021-2032)
- 6.2.1 Global Tiopronin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tiopronin Revenue Market Share by Type (2021-2032)
- 6.3 Global Tiopronin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tiopronin Sales by Application (2021-2032)
- 7.1.1 Global Tiopronin Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Tiopronin Sales Market Share by Application (2021-2032)
- 7.2 Global Tiopronin Revenue by Application (2021-2032)
- 7.2.1 Global Tiopronin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tiopronin Revenue Market Share by Application (2021-2032)
- 7.3 Global Tiopronin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tiopronin Value Chain Analysis
- 8.1.1 Tiopronin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tiopronin Production Mode & Process
- 8.2 Tiopronin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tiopronin Distributors
- 8.2.3 Tiopronin Customers
9 Global Tiopronin Analyzing Market Dynamics
- 9.1 Tiopronin Industry Trends
- 9.2 Tiopronin Industry Drivers
- 9.3 Tiopronin Industry Opportunities and Challenges
- 9.4 Tiopronin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst